Results 11 to 20 of about 94,588 (272)
Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab-PLGA microspheres in rabbits [PDF]
International Journal of Ophthalmology, 2015 AIM:To investigate the pharmacokinetics and distributions of bevacizumab by intravitreal injection of prepared bevacizumab-poly (L-lactic-co-glycolic acid) (PLGA) microspheres in rabbits, to provide evidence for clinical application of this kind of ...
Zhuo Ye +5 more
doaj +2 more sources
Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
Clinical Ophthalmology, 2011 Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, Comer GM
doaj +2 more sources
Clinical Ophthalmology, 2011 Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal ...
Gondo M, Sakai T, Tsuneoka H, Kanehira C
doaj +2 more sources
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
Clinical Ophthalmology, 2011 Mehmet Demir, Ersin Oba, Gökhan Gulkilik, Mahmut Odabasi, Erhan OzdalSisli Etfal Training and Research Hospital, Eye Clinic, Sisli, Istanbul, TurkeyPurpose: To present the functional and anatomic changes after intravitreal bevacizumab in eyes ...
Demir M +4 more
doaj +1 more source
Case of endophthalmitis following intravitreal injections of bevacizumab
Clinical Ophthalmology, 2010 Shinya Komori1, Akira Sawada1, Tsutomu Oguni1, Kiyofumi Mochizuki1, Kiyofumi Ohkusu21Department of Ophthalmology, 2Department of Microbiology, Gifu University Graduate School of Medicine, Gifu, JapanPurpose: We report a case of infectious endophthalmitis
Shinya Komori +3 more
doaj +1 more source
Therapeutics and Clinical Risk Management, 2010 Eleni Loukianou, Dimitrios Brouzas, Eleni Georgopoulou, Chrysanthi Koutsandrea, Michael ApostolopoulosEye Department, University of Athens, Athens, GreecePurpose: To evaluate the safety and efficacy of intravitreal injections of bevacizumab (Avastin& ...
Eleni Loukianou +3 more
doaj +1 more source
Clinical Ophthalmology, 2011 Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP)
Marey HM, Ellakwa AF
doaj +1 more source
Intravitreal bevacizumab for vitreous hemorrhage [PDF]
Acta Ophthalmologica, 2008 Abstract Purpose Vitreous hemorrage is one of the major complications of ischemic retinopathies such as diabetic retinopathy. Our purpose was to describe the clinical outcome of patients who underwent a less invasive intervention than vitrectomy for therapy of persisting vitreous hemorrage Methods Our clinical interventional case series study included ...
Jost B, Jonas +3 more
openaire +2 more sources
Intravitreal Bevacizumab for Neovascular Glaucoma [PDF]
Journal of Ocular Pharmacology and Therapeutics, 2009 Purpose: To report 6-month and 1 year outcomes of eyes treated for neovascular glaucoma (NVG) with intravitreal bevacizumab injection and panretinal laser (PRP) compared to those receiving PRP alone. Design: retrospective, consecutive ...
Deepta, Vasudev +4 more
openaire +4 more sources
Ophthalmology (Rochester, Minn.), 2020 PURPOSE Intravitreal anti-VEGF pharmacotherapy plays a central role in the management of neovascular age-related macular degeneration (nAMD), diabetic retinal disease (DRD), and retinal venous occlusive disease (RVO).
Maya H. Maloney +5 more
semanticscholar +1 more source